These findings indicate that insulin may play an inhibitory role in regulating ZAG expression, positioning ZAG not only as a key player in the pathogenesis of obesity and metabolic syndrome but also as a potential therapeutic target [12,18]. This evidence concerns the gene AZGP1 and obesity disorder.